Inventor
CHU ZHI-LIANG
US20 patents
⚠️ This page may combine multiple inventors who share the name “CHU ZHI-LIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
15 patentsUS8354241B2Jan 15, 2013
Methods for identifying a GLP-1 secretagogue
ARENA PHARM INC5 citations73
US7833730B2Nov 16, 2010
Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
ARENA PHARM INC4 citations73
US7803753B2Sep 28, 2010
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
ARENA PHARM INC6 citations73
US7838254B2Nov 23, 2010
Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
ARENA PHARM INC2 citations63
US8030270B2Oct 4, 2011
Methods for identifying GLP-1 secretagogues
ARENA PHARM INC2 citations62
US8026074B2Sep 27, 2011
Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
ARENA PHARM INC2 citations62
US8026212B2Sep 27, 2011
Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues
ARENA PHARM INC2 citations62
US8022034B2Sep 20, 2011
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
ARENA PHARM INC2 citations62
US8017574B2Sep 13, 2011
Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues
ARENA PHARM INC2 citations62
US8003597B2Aug 23, 2011
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
ARENA PHARM INC2 citations62
US7816364B2Oct 19, 2010
GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
ARENA PHARM INC4 citations62
US7803754B2Sep 28, 2010
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
ARENA PHARM INC2 citations62
US9182414B2Nov 10, 2015
Methods for identifying a GLP-1 secretagogue
ARENA PHARM INC1 citations52
US8883714B2Nov 11, 2014
Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues
ARENA PHARM INC0 citations52
US8039219B2Oct 18, 2011
Method of using GPR35 to identify metabolic-stabilizing compounds
ARENA PHARM INC0 citations52
CHU ZHI-LIANG
4 patentsUS8198232B2Jun 12, 2012
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
CHU ZHI-LIANG5 citations72
US8580526B2Nov 12, 2013
Methods of using GPR119 receptor to identify compounds which stimulate glucose-dependent insulinotropic peptide secretion
CHU ZHI-LIANG3 citations61
US8486646B2Jul 16, 2013
Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues
CHU ZHI-LIANG3 citations61
US8101626B2Jan 24, 2012
GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
CHU ZHI-LIANG4 citations61